Follow
Hari Bhaskaran
Hari Bhaskaran
Scientist, technology development
No verified email
Title
Cited by
Cited by
Year
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
R De Alwis, ES Gan, S Chen, YS Leong, HC Tan, SL Zhang, C Yau, ...
Molecular Therapy 29 (6), 1970-1983, 2021
1492021
Kinetic redistribution of native and misfolded RNAs by a DEAD-box chaperone
H Bhaskaran, R Russell
Nature 449 (7165), 1014-1018, 2007
1382007
Nonspecific binding to structured RNA and preferential unwinding of an exposed helix by the CYT-19 protein, a DEAD-box RNA chaperone
P Tijerina, H Bhaskaran, R Russell
Proceedings of the National Academy of Sciences 103 (45), 16698-16703, 2006
1172006
Probing the mechanisms of DEAD-box proteins as general RNA chaperones: the C-terminal domain of CYT-19 mediates general recognition of RNA
JK Grohman, M Del Campo, H Bhaskaran, P Tijerina, AM Lambowitz, ...
Biochemistry 46 (11), 3013-3022, 2007
902007
Do DEAD-box proteins promote group II intron splicing without unwinding RNA?
M Del Campo, P Tijerina, H Bhaskaran, S Mohr, Q Yang, E Jankowsky, ...
Molecular cell 28 (1), 159-166, 2007
822007
The ATPase Fap7 tests the ability to carry out translocation-like conformational changes and releases Dim1 during 40S ribosome maturation
H Ghalei, J Trepreau, JC Collins, H Bhaskaran, BS Strunk, K Karbstein
Molecular cell 67 (6), 990-1000. e3, 2017
622017
Kinetics of tRNA folding monitored by aminoacylation
H Bhaskaran, A Rodriguez-Hernandez, JJ Perona
Rna 18 (3), 569-580, 2012
452012
Deletion of the P5abc Peripheral Element Accelerates Early and Late Folding Steps of the Tetrahymena Group I Ribozyme
R Russell, P Tijerina, AB Chadee, H Bhaskaran
Biochemistry 46 (17), 4951-4961, 2007
292007
DEAD-box protein CYT-19 is activated by exposed helices in a group I intron RNA
I Jarmoskaite, H Bhaskaran, S Seifert, R Russell
Proceedings of the National Academy of Sciences 111 (29), E2928-E2936, 2014
272014
Two-step aminoacylation of tRNA without channeling in Archaea
H Bhaskaran, JJ Perona
Journal of molecular biology 411 (4), 854-869, 2011
252011
Synthesis of Glu-tRNAGln by Engineered and Natural Aminoacyl-tRNA Synthetases
A Rodríguez-Hernández, H Bhaskaran, A Hadd, JJ Perona
Biochemistry 49 (31), 6727-6736, 2010
252010
Structural dynamics of a mitochondrial tRNA possessing weak thermodynamic stability
H Bhaskaran, T Taniguchi, T Suzuki, T Suzuki, JJ Perona
Biochemistry 53 (9), 1456-1465, 2014
112014
Protein roles in group I intron RNA folding: the tyrosyl-tRNA synthetase CYT-18 stabilizes the native state relative to a long-lived misfolded structure without compromising …
AB Chadee, H Bhaskaran, R Russell
Journal of molecular biology 395 (3), 656-670, 2010
112010
In vitro selection of enteric microflora for potential use as a competitive exclusion culture against Campylobacter in poultry
HP Bhaskaran, AM Donoghue, K Arsi, A Wooming, I Reyes-Herrera, ...
Int. J. Poult. Sci 10 (12), 940-945, 2011
92011
mRNA therapy for ornithine transcarbamylase deficiency
M Sablad, Y Bao, J Vega, H Bhaskaran, C Perez-Garcia, J Gonzalez, ...
Society for Inherited Metabolic Disorders (SIMD) Conference, 2019
12019
Compositions and methods for treating phenylketonuria
K Tachikawa, CG Perez-garcia, P Chivukula, H Bhaskaran, SC Daugherty, ...
US Patent 11,939,600, 2024
2024
Method of purifying mRNA using substrate dependent ribozyme and solid-support attachment tag
H Bhaskaran
US Patent App. 18/072,674, 2023
2023
Therapeutics for glycogen storage disease type iii
K Tachikawa, CG Perez-garcia, P Chivukula, H Bhaskaran, CW Cobaugh, ...
US Patent App. 17/736,798, 2022
2022
Therapeutics for glycogen storage disease type III
K Tachikawa, CG Perez-garcia, P Chivukula, H Bhaskaran, CW Cobaugh, ...
US Patent 11,377,643, 2022
2022
THERAPEUTIC AGENTS FOR GLYCOGEN STORAGE DISEASE TYPE III
K Tachikawa, CG PEREZ-GARCIA, P Chivukula, HP BHASKARAN, ...
2021
The system can't perform the operation now. Try again later.
Articles 1–20